Sign in to view content

Risk of Sight-Threatening Diabetic Retinopathy with GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes

Andrew J. Barkmeier, MD

Video
Published 2024

Related

Presumed Silicone Oil Droplets
Rahul N. Khurana, MD, FASRS
Updates from the Field
2017
Diabetic Retinopathy Part I Take-Home Panel
Charles C Wykoff, MD, PhD, FASRS
Annual Meeting Talks
2019
Remarkable Findings From Steroids for DME Studies
Rishi P. Singh, MD
Updates from the Field
2017

Category: Diabetic Retinopathy

See more